BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 12238845)

  • 1. Clinical performance and biocompatibility of poly(2-methoxyethylacrylate)-coated extracorporeal circuits.
    Gunaydin S; Farsak B; Kocakulak M; Sari T; Yorgancioglu C; Zorlutuna Y
    Ann Thorac Surg; 2002 Sep; 74(3):819-24. PubMed ID: 12238845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical performance and biocompatibility of novel hyaluronan-based heparin-bonded extracorporeal circuits.
    Gunaydin S; Mccusker K; Vijay V
    J Extra Corpor Technol; 2005 Sep; 37(3):290-5. PubMed ID: 16350383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biocompatibility of heparin-coated cardiopulmonary bypass circuits in coronary patients with left ventricular dysfunction is superior to PMEA-coated circuits.
    Kutay V; Noyan T; Ozcan S; Melek Y; Ekim H; Yakut C
    J Card Surg; 2006; 21(6):572-7. PubMed ID: 17073955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of polymethoxyethylacrylate-coated circuits with leukocyte filtration and reduced heparinization protocol on heparin-bonded circuits in different risk cohorts.
    Gunaydin S; McCusker K; Vijay V; Isbir S; Sari T; Onur MA; Gurpinar A; Sezgin A; Sargon MF; Tezcaner T; Zorlutuna Y
    Perfusion; 2006 Nov; 21(6):329-42. PubMed ID: 17312857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and biomaterial evaluation of a new condensed dual-function extracorporeal circuit in reoperation for coronary artery bypass surgery.
    Gunaydin S; McCusker K; Vijay V
    Int J Artif Organs; 2009 Nov; 32(11):802-10. PubMed ID: 20020412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo comparison study of FDA-approved surface-modifying additives and poly-2-methoxyethylacrylate circuit surfaces coatings during cardiopulmonary bypass.
    Ask A; Holt D; Smith L
    J Extra Corpor Technol; 2006 Mar; 38(1):27-32. PubMed ID: 16637520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemocompatibility of PMEA coated oxygenators used for extracorporeal circulation procedures.
    Zimmermann AK; Aebert H; Reiz A; Freitag M; Husseini M; Ziemer G; Wendel HP
    ASAIO J; 2004; 50(3):193-9. PubMed ID: 15171468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of poly (2-methoxyethyl acrylate)-coated oxygenators on haemolysis.
    Kocakulak M; Ozgürtaş T; Ayhan H
    J Biomater Sci Polym Ed; 2006; 17(4):449-60. PubMed ID: 16768295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and biomaterial evaluation of hyaluronan-based heparin-bonded extracorporeal circuits with reduced versus full systemic anticoagulation in reoperation for coronary revascularization.
    Gunaydin S; Farsak B; McCusker K; Vijay V; Sari T; Onur MA; Gurpinar A; Zorlutuna Y
    J Cardiovasc Med (Hagerstown); 2009 Feb; 10(2):135-42. PubMed ID: 19377380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new poly-2-methoxyethylacrylate-coated cardiopulmonary bypass circuit possesses superior platelet preservation and inflammatory suppression efficacy.
    Ikuta T; Fujii H; Shibata T; Hattori K; Hirai H; Kumano H; Suehiro S
    Ann Thorac Surg; 2004 May; 77(5):1678-83. PubMed ID: 15111165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of biocompatible cardiopulmonary bypass circuit use during pediatric open heart surgery.
    Deptula J; Glogowski K; Merrigan K; Hanson K; Felix D; Hammel J; Duncan K
    J Extra Corpor Technol; 2006 Mar; 38(1):22-6. PubMed ID: 16637519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical performance and biocompatibility of hyaluronan-based heparin-bonded extracorporeal circuits in different risk cohorts.
    Gunaydin S; McCusker K; Sari T; Onur MA; Zorlutuna Y
    Interact Cardiovasc Thorac Surg; 2010 Mar; 10(3):371-6. PubMed ID: 20026488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Poly-2-methoxyethylacrylate-coated cardiopulmonary bypass circuit can reduce transfusion of platelet products compared to heparin-coated circuit during aortic arch surgery.
    Hosoyama K; Ito K; Kawamoto S; Kumagai K; Akiyama M; Adachi O; Kawatsu S; Sasaki K; Suzuki M; Sugawara Y; Shimizu Y; Saiki Y
    J Artif Organs; 2016 Sep; 19(3):233-40. PubMed ID: 26909493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of PMEA-coated bypass circuits on perioperative inflammatory response.
    Ninomiya M; Miyaji K; Takamoto S
    Ann Thorac Surg; 2003 Mar; 75(3):913-7; discussion 917-8. PubMed ID: 12645716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New surface biopolymers for oxygenators: an in vitro hemocompatibility test of poly(2-methoxyethylacrylate).
    Baykut D; Bernet F; Wehrle J; Weichelt K; Schwartz P; Zerkowski HR
    Eur J Med Res; 2001 Jul; 6(7):297-305. PubMed ID: 11485890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical evaluation of poly(2-methoxyethylacrylate) in primary coronary artery bypass grafting.
    Vang SN; Brady CP; Christensen KA; Isler JR; Allen KR
    J Extra Corpor Technol; 2005 Mar; 37(1):23-31. PubMed ID: 15804153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of polymer coating (poly 2-methoxyethylacrylate) of the oxygenator on hemostatic markers during cardiopulmonary bypass in children.
    Eisses MJ; Geiduschek JM; Jonmarker C; Cohen GA; Chandler WL
    J Cardiothorac Vasc Anesth; 2007 Feb; 21(1):28-34. PubMed ID: 17289476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biocompatibility of heparin-coated extracorporeal bypass circuits: a randomized, masked clinical trial.
    Muehrcke DD; McCarthy PM; Kottke-Marchant K; Harasaki H; Pierre-Yared J; Borsh JA; Ogella DA; Cosgrove DM
    J Thorac Cardiovasc Surg; 1996 Aug; 112(2):472-83. PubMed ID: 8751516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Poly2-methoxyethylacrylate (PMEA) coated oxygenator: an ex vivo study.
    Mueller XM; Jegger D; Augstburger M; Horisberger J; von Segesser LK
    Int J Artif Organs; 2002 Mar; 25(3):223-9. PubMed ID: 11999195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PMEA coating of pump circuit and oxygenator may attenuate the early systemic inflammatory response in cardiopulmonary bypass surgery.
    Ueyama K; Nishimura K; Nishina T; Nakamura T; Ikeda T; Komeda M
    ASAIO J; 2004; 50(4):369-72. PubMed ID: 15307550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.